Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate Cancer. - Burkhart DL; Morel KL; Wadosky KM; Labbé DP; Galbo PM; Dalimov Z; Xu B; Loda M; Ellis L (Cancer prevention research (Philadelphia, Pa.), 2020)